NYSE:RVTYLife Sciences
Revvity Expands Drug Discovery Tools As Investors Weigh Growth And Valuation
Revvity (NYSE:RVTY) introduced several new discovery platforms at SLAS2026, aimed at speeding up high-throughput drug discovery workflows.
The launches include an advanced high-content screening system, a multimode plate reader, and a compact liquid handler for integrated lab setups.
These products expand Revvity's portfolio in life sciences tools and are designed to support more efficient discovery programs.
For investors watching NYSE:RVTY, this product launch comes as the shares trade at...